BMRN
Biomarin Pharmaceutical Inc
$56.21
+1.28% (+$0.71)
Volume
1.86M
52W High
$68.54
52W Low
$50.76
Market Cap
$12.31B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.97
Whisper EPS
$0.82
15.0% below consensus
Last Quarter
$0.46
Current Streak
3 Misss
Avg Surprise (4Q)
-49.56%
Next Earnings Report
Reports in 30 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q4 2025
Feb 25, 2026
1-Day:
-0.54%
5-Day:
-2.77%
Q4 2025
Feb 23, 2026
1-Day:
-0.48%
Q4 2025
Feb 18, 2026
1-Day:
+2.57%
5-Day:
+1.76%
Q3 2025
Oct 27, 2025
1-Day:
+1.56%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $874.6M | +17.0% | 66.3% | 9.1% | -$46.6M |
| Q3'25 | $776.1M | +4.1% | 82.0% | -6.0% | -$30.7M |
| Q2'25 | $825.4M | +15.9% | 81.8% | 33.6% | $240.5M |
| Q1'25 | $745.1M | +14.8% | 79.7% | 30.1% | $185.7M |
| Q4'24 | $747.3M | +15.7% | 81.8% | 21.6% | $124.9M |
| Q3'24 | $745.7M | +28.3% | 74.7% | 15.3% | $106.1M |
| Q2'24 | $712.0M | +19.6% | 81.7% | 16.9% | $107.2M |
| Q1'24 | $648.8M | +8.8% | 80.7% | 13.6% | $88.7M |
Company Information
Symbol
BMRN
Company
Biomarin Pharmaceutical Inc
Market Cap
$12.31B
Next Earnings
May 7, 2026